Zubsolv (buprenorphine/naloxone sublingual tablet) / Orexo, Mundipharma 
Welcome,         Profile    Billing    Logout  
 2 Diseases   1 Trial   1 Trial   409 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zubsolv (buprenorphine/naloxone sublingual tablet) / Orexo, Mundipharma
ED-ENVISION, NCT06494904: Standard Versus High Dose ED-Initiated Buprenorphine Induction

Not yet recruiting
3
360
US
Buprenorphine, Zubsolv
Yale University, National Drug Abuse Treatment Clinical Trials Network, The Emmes Company, LLC, National Institute on Drug Abuse (NIDA), Alameda Health System
Opioid Use Disorder
04/27
12/28
COMBO, NCT05011266: Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Recruiting
2/3
180
US
Buprenorphine/naloxone, Zubsolv, Placebo, PBO
New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA)
Opioid-use Disorder
06/26
06/26

Download Options